Change in humor and sarcasm use based on anxiety and depression symptom severity during the COVID-19 pandemic.
J Psychiatr Res
; 140: 95-100, 2021 08.
Article
in English
| MEDLINE | ID: covidwho-1240462
ABSTRACT
BACKGROUND:
Humor and sarcasm may be used as potential coping strategies during challenging times, and to improve wellbeing. We investigated changes in humor and sarcasm use during the COVID-19 pandemic in participants with varying anxiety and depression symptom severity, and in those with versus without psychiatric disorders.METHODS:
Online data was collected from N = 661 Canadian adults during the height of COVID-19-related restrictions. Depression and anxiety symptom severity were assessed using the Patient Health Questionnaire (PHQ-9) and General Anxiety Disorder (GAD-7) scale. Participants were queried on current presence/absence of a psychiatric disorder, and on changes in humor and sarcasm use during compared to before the pandemic.RESULTS:
Participants with any vs. no depression symptoms reported more sarcasm and humor use during the pandemic. Respondents with mild and severe vs. no anxiety symptoms reported using more sarcasm. However, those with any vs. no anxiety symptoms used less humor during the pandemic. Finally, less humor use was noted in those without vs. with a psychiatric disorder.LIMITATIONS:
The use of self-report measures and a sample that may limit generalizability.CONCLUSIONS:
Adults with depression symptoms used more humor and sarcasm as a potential coping strategy during COVID-19. While individuals with anxiety symptoms used more sarcasm, this was not true of humor, suggesting their decreased reliance on levity during a crisis. Humor use was greater in those with psychiatric disorders, perhaps due to self-preservation mechanisms during times of distress. Our findings have implications for using humor in therapy in individuals with mental health struggles and mood disorders.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pandemics
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Adult
/
Humans
Country/Region as subject:
North America
Language:
English
Journal:
J Psychiatr Res
Year:
2021
Document Type:
Article
Affiliation country:
J.jpsychires.2021.05.027
Similar
MEDLINE
...
LILACS
LIS